# Liposomal Bupivacaine vs Ropivacaine for TAPBs

> **NCT06430112** · PHASE3 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 74 (estimated)

## Conditions studied

- Abdominal Tumor
- Postoperative Analgesia
- Liposomal Bupivacaine
- Ropivacaine

## Interventions

- **DRUG:** Liposomal Bupivacaine
- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT06430112
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-01
- **Primary completion:** 2024-05-20
- **Final completion:** 2024-06
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2024-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06430112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06430112, "Liposomal Bupivacaine vs Ropivacaine for TAPBs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06430112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*